Skip to content

Prospective study of cirrhotic patients with infection

Prospective study of cirrhotic patients with infection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072488
Enrollment
Unknown
Registered
2023-06-15
Start date
2023-06-15
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cirrhotic with infection

Interventions

none:none

Sponsors

The First Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 8 Years

Inclusion criteria

Inclusion criteria: Patients with cirrhosis of the liver who were admitted to hospital with concurrent infection and infection after admission from September 1, 2022-September 1, 2023 were included

Exclusion criteria

Exclusion criteria: (1) Under the age of 18; (2) pregnancy; (3) Confirmed or suspected malignant tumor; (4) Severe chronic diseases of extrahepatic organs: heart failure (NYHA grade =3), chronic obstructive pulmonary disease (GOLD grade =3), chronic kidney disease requiring renal replacement therapy; (5) previous solid organ transplantation; (6) human immunodeficiency virus infection; (7) Use of glucocorticoids and immunosuppressants for treatment of diseases other than underlying liver disease;

Design outcomes

Primary

MeasureTime frame
Prevalence of MDR, XDR bacteria;

Secondary

MeasureTime frame
In-hospital outcomes;Outcomes AT 28 DAYS;Outcomes AT 90 DAYS;Incidence of acute events during hospitalization;

Countries

China

Contacts

Public ContactYu Shi

The First Affiliated Hospital, College of Medicine, Zhejiang University

zjushiyu@zju.edu.cn+86 159 8815 6155

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026